Scholars@Duke

Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2.

Publication ,  Journal Article
Luedke, C; Rein, L
Published in: Blood
August 27, 2020
Published version (DOI) Link to item

Duke Scholars

Lindsay Anne Magura Rein
Author Lindsay Anne Magura Rein Medicine, Hematologic Malignancies and Cellular Therapy
Altmetric Attention Stats
Dimensions Citation Stats

Published In

Blood

DOI

10.1182/blood.2019004410

EISSN

1528-0020

Publication Date

August 27, 2020

Volume

136

Issue

9

Start / End Page

1113

Location

United States

Related Subject Headings

  • Sarcoma, Myeloid
  • Oncogene Proteins, Fusion
  • Male
  • Lymph Nodes
  • Immunology
  • Humans
  • Erythroblasts
  • Disease Progression
  • Bone Marrow Neoplasms
  • Biomarkers, Tumor
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Luedke, C., & Rein, L. (2020). Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2. Blood, 136(9), 1113. https://doi.org/10.1182/blood.2019004410
Luedke, Catherine, and Lindsay Rein. “Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2.” Blood 136, no. 9 (August 27, 2020): 1113. https://doi.org/10.1182/blood.2019004410.
Luedke, Catherine, and Lindsay Rein. “Transformation to erythroblastic sarcoma from myeloid neoplasm with PCM1-JAK2.” Blood, vol. 136, no. 9, Aug. 2020, p. 1113. Pubmed, doi:10.1182/blood.2019004410.

Published In

Blood

DOI

10.1182/blood.2019004410

EISSN

1528-0020

Publication Date

August 27, 2020

Volume

136

Issue

9

Start / End Page

1113

Location

United States

Related Subject Headings

  • Sarcoma, Myeloid
  • Oncogene Proteins, Fusion
  • Male
  • Lymph Nodes
  • Immunology
  • Humans
  • Erythroblasts
  • Disease Progression
  • Bone Marrow Neoplasms
  • Biomarkers, Tumor